Amanda Toye, MD
Pain Medicine · Nashville, TNNPI 1346440914
Payments from drug & device makers
Across 73 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$488
- Boston Scientific$209
- SPR Therapeutics, Inc$141
- Saluda Medical Americas, Inc.$131
- Pfizer$112
- Medtronic$106
- plus $687 from 15 others
What the payments were for
- Food & beverage$1,874100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 10 | $488 |
| Boston Scientific | 7 | $209 |
| SPR Therapeutics, Inc | 1 | $141 |
| Saluda Medical Americas, Inc. | 1 | $131 |
| Pfizer | 14 | $112 |
| Medtronic(2 entities) | 2 | $106 |
| Heron Therapeutics, Inc. | 1 | $90 |
| Collegium Pharmaceutical, Inc. | 6 | $85 |
| Nevro Corp. | 3 | $80 |
| Daiichi Sankyo Inc. | 5 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Sentynl Therapeutics, Inc. | 3 | $53 |
| Novartis | 2 | $44 |
| Amgen | 2 | $35 |
| Stimwave Technologies Incorporated | 2 | $35 |
| MDD US Operations, LLC | 2 | $31 |
| Biodelivery Sciences International, Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| AbbVie | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$141
- Evoke SCS$131
How this compares
$1,874 in reported general payments places this provider in the 45th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 39 | $9,428 |
| Gabapentin | 49 | $1,255 |
| Pregabalin | 39 | $1,094 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $572 |
| Oxycodone Hcl | 24 | $465 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $332 |
| Duloxetine Hcl | 21 | $295 |
| Celecoxib | 11 | $284 |
| Methocarbamol | 34 | $248 |
| Cyclobenzaprine Hcl | 17 | $160 |
| Baclofen | 11 | $116 |
| Tizanidine Hcl | 11 | $81 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Nashville
- Herbert MeltzerNashville$974K
- Damita BryantNashville$506K
- Shravani DurbhakulaNashville$468K
- Marc HuntoonNashville$37K
- Puneet MishraNashville$32K
- Jeremy WalkerNashville$25K
- Tigran KesayanNashville$13K
- Alex SchmidtNashville$10K
- Christopher SobeyNashville$10K
- Victor IsaacNashville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.